Corgenix to Host Conference Call to Discuss Major Strategic Collaboration and Investment from the ELITech Group

DENVER, July 16 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Wednesday, July 21, 2010, at 4:00 PM EDT to discuss the Company's announced major collaboration and investment from the ELITech Group, a Paris, France-based, privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic equipment and reagents. The Form 8-K related to this transaction has been filed with the Securities and Exchange Commission today, July 16, 2010, and will be followed by a press release next Monday, July 19, 2010.

Corgenix invites all those interested in hearing management's discussion to join the call by dialing:

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 839-2382 for U.S. participants and +1 402 220 7201 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com.

SOURCE Corgenix Medical Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED